Global and United States Intravitreal Injectable Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.

Market Analysis and Insights: Global and United States Intravitreal Injectable Market
This report focuses on global and United States Intravitreal Injectable market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Intravitreal Injectable market size is estimated to be worth US$ 15650 million in 2022 and is forecast to a readjusted size of US$ 23620 million by 2028 with a CAGR of 7.1% during the review period. Fully considering the economic change by this health crisis, by Drug, Anti-VEGF accounting for % of the Intravitreal Injectable global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Disease, Macular Degeneration was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.

North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.

Global Intravitreal Injectable Scope and Market Size
Intravitreal Injectable market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Intravitreal Injectable market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Intravitreal Injectable market size by players, by Drug and by Disease, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Drug, the Intravitreal Injectable market is segmented into
    Anti-VEGF
    Steroids
    Others

Segment by Disease, the Intravitreal Injectable market is segmented into
    Macular Degeneration
    Macular Edema
    Uveitis
    Retinal Vein Occlusion
    Others

Regional and Country-level Analysis
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Intravitreal Injectable Market Share Analysis
Intravitreal Injectable market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Intravitreal Injectable business, the date to enter into the Intravitreal Injectable market, Intravitreal Injectable product introduction, recent developments, etc.

The major vendors covered:
    Regeneron Pharmaceuticals (Eylea)
    Allergan
    EyePoint Pharmaceuticals
    Genentech
    Kanghong Pharmaceutical

 1 Study Coverage
    1.1 Intravitreal Injectable Product Introduction
    1.2 Global Intravitreal Injectable Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Intravitreal Injectable Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Intravitreal Injectable Sales in Volume for the Year 2017-2028
    1.3 United States Intravitreal Injectable Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Intravitreal Injectable Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Intravitreal Injectable Sales in Volume for the Year 2017-2028
    1.4 Intravitreal Injectable Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Intravitreal Injectable in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Intravitreal Injectable Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Intravitreal Injectable Market Dynamics
        1.5.1 Intravitreal Injectable Industry Trends
        1.5.2 Intravitreal Injectable Market Drivers
        1.5.3 Intravitreal Injectable Market Challenges
        1.5.4 Intravitreal Injectable Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Drug
    2.1 Intravitreal Injectable Market Segment by Drug
        2.1.1 Anti-VEGF
        2.1.2 Steroids
        2.1.3 Others
    2.2 Global Intravitreal Injectable Market Size by Drug
        2.2.1 Global Intravitreal Injectable Sales in Value, by Drug (2017, 2022 & 2028)
        2.2.2 Global Intravitreal Injectable Sales in Volume, by Drug (2017, 2022 & 2028)
        2.2.3 Global Intravitreal Injectable Average Selling Price (ASP) by Drug (2017, 2022 & 2028)
    2.3 United States Intravitreal Injectable Market Size by Drug
        2.3.1 United States Intravitreal Injectable Sales in Value, by Drug (2017, 2022 & 2028)
        2.3.2 United States Intravitreal Injectable Sales in Volume, by Drug (2017, 2022 & 2028)
        2.3.3 United States Intravitreal Injectable Average Selling Price (ASP) by Drug (2017, 2022 & 2028)

 3 Market by Disease
    3.1 Intravitreal Injectable Market Segment by Disease
        3.1.1 Macular Degeneration
        3.1.2 Macular Edema
        3.1.3 Uveitis
        3.1.4 Retinal Vein Occlusion
        3.1.5 Others
    3.2 Global Intravitreal Injectable Market Size by Disease
        3.2.1 Global Intravitreal Injectable Sales in Value, by Disease (2017, 2022 & 2028)
        3.2.2 Global Intravitreal Injectable Sales in Volume, by Disease (2017, 2022 & 2028)
        3.3.3 Global Intravitreal Injectable Average Selling Price (ASP) by Disease (2017, 2022 & 2028)
    3.3 United States Intravitreal Injectable Market Size by Disease
        3.3.1 United States Intravitreal Injectable Sales in Value, by Disease (2017, 2022 & 2028)
        3.3.2 United States Intravitreal Injectable Sales in Volume, by Disease (2017, 2022 & 2028)
        3.3.3 United States Intravitreal Injectable Average Selling Price (ASP) by Disease (2017, 2022 & 2028)

 4 Global Intravitreal Injectable Competitor Landscape by Company
    4.1 Global Intravitreal Injectable Market Size by Company
        4.1.1 Top Global Intravitreal Injectable Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Intravitreal Injectable Revenue by Manufacturer (2017-2022)
        4.1.3 Global Intravitreal Injectable Sales by Manufacturer (2017-2022)
        4.1.4 Global Intravitreal Injectable Price by Manufacturer (2017-2022)
    4.2 Global Intravitreal Injectable Concentration Ratio (CR)
        4.2.1 Intravitreal Injectable Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Intravitreal Injectable in 2021
        4.2.3 Global Intravitreal Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Intravitreal Injectable Manufacturing Base Distribution, Product Type
        4.3.1 Global Intravitreal Injectable Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Intravitreal Injectable Product Type
        4.3.3 Date of International Manufacturers Enter into Intravitreal Injectable Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Intravitreal Injectable Market Size by Company
        4.5.1 Top Intravitreal Injectable Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Intravitreal Injectable Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Intravitreal Injectable Sales by Players (2020, 2021 & 2022)

 5 Global Intravitreal Injectable Market Size by Region
    5.1 Global Intravitreal Injectable Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Intravitreal Injectable Market Size in Volume by Region (2017-2028)
        5.2.1 Global Intravitreal Injectable Sales in Volume by Region: 2017-2022
        5.2.2 Global Intravitreal Injectable Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Intravitreal Injectable Market Size in Value by Region (2017-2028)
        5.3.1 Global Intravitreal Injectable Sales in Value by Region: 2017-2022
        5.3.2 Global Intravitreal Injectable Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Intravitreal Injectable Market Size YoY Growth 2017-2028
        6.1.2 North America Intravitreal Injectable Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Intravitreal Injectable Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Intravitreal Injectable Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Intravitreal Injectable Market Size YoY Growth 2017-2028
        6.3.2 Europe Intravitreal Injectable Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Intravitreal Injectable Market Size YoY Growth 2017-2028
        6.4.2 Latin America Intravitreal Injectable Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Intravitreal Injectable Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Intravitreal Injectable Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Regeneron Pharmaceuticals (Eylea)
        7.1.1 Regeneron Pharmaceuticals (Eylea) Corporation Information
        7.1.2 Regeneron Pharmaceuticals (Eylea) Description and Business Overview
        7.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Products Offered
        7.1.5 Regeneron Pharmaceuticals (Eylea) Recent Development
    7.2 Allergan
        7.2.1 Allergan Corporation Information
        7.2.2 Allergan Description and Business Overview
        7.2.3 Allergan Intravitreal Injectable Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Allergan Intravitreal Injectable Products Offered
        7.2.5 Allergan Recent Development
    7.3 EyePoint Pharmaceuticals
        7.3.1 EyePoint Pharmaceuticals Corporation Information
        7.3.2 EyePoint Pharmaceuticals Description and Business Overview
        7.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Products Offered
        7.3.5 EyePoint Pharmaceuticals Recent Development
    7.4 Genentech
        7.4.1 Genentech Corporation Information
        7.4.2 Genentech Description and Business Overview
        7.4.3 Genentech Intravitreal Injectable Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Genentech Intravitreal Injectable Products Offered
        7.4.5 Genentech Recent Development
    7.5 Kanghong Pharmaceutical
        7.5.1 Kanghong Pharmaceutical Corporation Information
        7.5.2 Kanghong Pharmaceutical Description and Business Overview
        7.5.3 Kanghong Pharmaceutical Intravitreal Injectable Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Kanghong Pharmaceutical Intravitreal Injectable Products Offered
        7.5.5 Kanghong Pharmaceutical Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Intravitreal Injectable Industry Chain Analysis
    8.2 Intravitreal Injectable Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Intravitreal Injectable Distributors
    8.3 Intravitreal Injectable Production Mode & Process
    8.4 Intravitreal Injectable Sales and Marketing
        8.4.1 Intravitreal Injectable Sales Channels
        8.4.2 Intravitreal Injectable Distributors
    8.5 Intravitreal Injectable Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Intravitreal Injectable CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Intravitreal Injectable Market Trends
    Table 3. Intravitreal Injectable Market Drivers
    Table 4. Intravitreal Injectable Market Challenges
    Table 5. Intravitreal Injectable Market Restraints
    Table 6. Global Intravitreal Injectable Sales by Drug: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Intravitreal Injectable Sales by Drug: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Intravitreal Injectable Sales by Disease: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Intravitreal Injectable Sales by Disease: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Intravitreal Injectable Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Intravitreal Injectable Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Intravitreal Injectable Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Intravitreal Injectable Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Intravitreal Injectable Sales Share by Manufacturer, 2017-2022
    Table 15. Global Intravitreal Injectable Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Intravitreal Injectable Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Intravitreal Injectable by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravitreal Injectable as of 2021)
    Table 18. Top Players of Intravitreal Injectable in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Intravitreal Injectable Product Type
    Table 20. Date of International Manufacturers Enter into Intravitreal Injectable Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Intravitreal Injectable Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Intravitreal Injectable Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Intravitreal Injectable Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Intravitreal Injectable Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Intravitreal Injectable Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Intravitreal Injectable Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Intravitreal Injectable Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Intravitreal Injectable Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Intravitreal Injectable Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Intravitreal Injectable Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Intravitreal Injectable Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Intravitreal Injectable Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Intravitreal Injectable Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Intravitreal Injectable Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Intravitreal Injectable Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Intravitreal Injectable Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Intravitreal Injectable Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Intravitreal Injectable Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Intravitreal Injectable Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Intravitreal Injectable Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Regeneron Pharmaceuticals (Eylea) Corporation Information
    Table 43. Regeneron Pharmaceuticals (Eylea) Description and Business Overview
    Table 44. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product
    Table 46. Regeneron Pharmaceuticals (Eylea) Recent Development
    Table 47. Allergan Corporation Information
    Table 48. Allergan Description and Business Overview
    Table 49. Allergan Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Allergan Product
    Table 51. Allergan Recent Development
    Table 52. EyePoint Pharmaceuticals Corporation Information
    Table 53. EyePoint Pharmaceuticals Description and Business Overview
    Table 54. EyePoint Pharmaceuticals Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. EyePoint Pharmaceuticals Product
    Table 56. EyePoint Pharmaceuticals Recent Development
    Table 57. Genentech Corporation Information
    Table 58. Genentech Description and Business Overview
    Table 59. Genentech Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Genentech Product
    Table 61. Genentech Recent Development
    Table 62. Kanghong Pharmaceutical Corporation Information
    Table 63. Kanghong Pharmaceutical Description and Business Overview
    Table 64. Kanghong Pharmaceutical Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Kanghong Pharmaceutical Product
    Table 66. Kanghong Pharmaceutical Recent Development
    Table 67. Key Raw Materials Lists
    Table 68. Raw Materials Key Suppliers Lists
    Table 69. Intravitreal Injectable Customers List
    Table 70. Intravitreal Injectable Distributors List
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Intravitreal Injectable Product Picture
    Figure 2. Global Intravitreal Injectable Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Intravitreal Injectable Market Size 2017-2028 (US$ Million)
    Figure 4. Global Intravitreal Injectable Sales 2017-2028 (K Units)
    Figure 5. United States Intravitreal Injectable Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Intravitreal Injectable Market Size 2017-2028 (US$ Million)
    Figure 7. United States Intravitreal Injectable Sales 2017-2028 (K Units)
    Figure 8. United States Intravitreal Injectable Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Intravitreal Injectable Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Intravitreal Injectable Report Years Considered
    Figure 11. Product Picture of Anti-VEGF
    Figure 12. Product Picture of Steroids
    Figure 13. Product Picture of Others
    Figure 14. Global Intravitreal Injectable Market Share by Drug in 2022 & 2028
    Figure 15. Global Intravitreal Injectable Sales in Value by Drug (2017-2028) & (US$ Million)
    Figure 16. Global Intravitreal Injectable Sales Market Share in Value by Drug (2017-2028)
    Figure 17. Global Intravitreal Injectable Sales by Drug (2017-2028) & (K Units)
    Figure 18. Global Intravitreal Injectable Sales Market Share in Volume by Drug (2017-2028)
    Figure 19. Global Intravitreal Injectable Price by Drug (2017-2028) & (US$/Unit)
    Figure 20. United States Intravitreal Injectable Market Share by Drug in 2022 & 2028
    Figure 21. United States Intravitreal Injectable Sales in Value by Drug (2017-2028) & (US$ Million)
    Figure 22. United States Intravitreal Injectable Sales Market Share in Value by Drug (2017-2028)
    Figure 23. United States Intravitreal Injectable Sales by Drug (2017-2028) & (K Units)
    Figure 24. United States Intravitreal Injectable Sales Market Share in Volume by Drug (2017-2028)
    Figure 25. United States Intravitreal Injectable Price by Drug (2017-2028) & (US$/Unit)
    Figure 26. Product Picture of Macular Degeneration
    Figure 27. Product Picture of Macular Edema
    Figure 28. Product Picture of Uveitis
    Figure 29. Product Picture of Retinal Vein Occlusion
    Figure 30. Product Picture of Others
    Figure 31. Global Intravitreal Injectable Market Share by Disease in 2022 & 2028
    Figure 32. Global Intravitreal Injectable Sales in Value by Disease (2017-2028) & (US$ Million)
    Figure 33. Global Intravitreal Injectable Sales Market Share in Value by Disease (2017-2028)
    Figure 34. Global Intravitreal Injectable Sales by Disease (2017-2028) & (K Units)
    Figure 35. Global Intravitreal Injectable Sales Market Share in Volume by Disease (2017-2028)
    Figure 36. Global Intravitreal Injectable Price by Disease (2017-2028) & (US$/Unit)
    Figure 37. United States Intravitreal Injectable Market Share by Disease in 2022 & 2028
    Figure 38. United States Intravitreal Injectable Sales in Value by Disease (2017-2028) & (US$ Million)
    Figure 39. United States Intravitreal Injectable Sales Market Share in Value by Disease (2017-2028)
    Figure 40. United States Intravitreal Injectable Sales by Disease (2017-2028) & (K Units)
    Figure 41. United States Intravitreal Injectable Sales Market Share in Volume by Disease (2017-2028)
    Figure 42. United States Intravitreal Injectable Price by Disease (2017-2028) & (US$/Unit)
    Figure 43. North America Intravitreal Injectable Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. North America Intravitreal Injectable Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. United States Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Intravitreal Injectable Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 48. Europe Intravitreal Injectable Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Intravitreal Injectable Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 55. Asia-Pacific Intravitreal Injectable Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. China Taiwan Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Intravitreal Injectable Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 66. Latin America Intravitreal Injectable Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Intravitreal Injectable Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 71. Middle East & Africa Intravitreal Injectable Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. UAE Intravitreal Injectable Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Intravitreal Injectable Value Chain
    Figure 76. Intravitreal Injectable Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed

Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.

Market Analysis and Insights: Global and United States Intravitreal Injectable Market
This report focuses on global and United States Intravitreal Injectable market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Intravitreal Injectable market size is estimated to be worth US$ 15650 million in 2022 and is forecast to a readjusted size of US$ 23620 million by 2028 with a CAGR of 7.1% during the review period. Fully considering the economic change by this health crisis, by Drug, Anti-VEGF accounting for % of the Intravitreal Injectable global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Disease, Macular Degeneration was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.

North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.

Global Intravitreal Injectable Scope and Market Size
Intravitreal Injectable market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Intravitreal Injectable market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Intravitreal Injectable market size by players, by Drug and by Disease, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Drug, the Intravitreal Injectable market is segmented into
    Anti-VEGF
    Steroids
    Others

Segment by Disease, the Intravitreal Injectable market is segmented into
    Macular Degeneration
    Macular Edema
    Uveitis
    Retinal Vein Occlusion
    Others

Regional and Country-level Analysis
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Intravitreal Injectable Market Share Analysis
Intravitreal Injectable market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Intravitreal Injectable business, the date to enter into the Intravitreal Injectable market, Intravitreal Injectable product introduction, recent developments, etc.

The major vendors covered:
    Regeneron Pharmaceuticals (Eylea)
    Allergan
    EyePoint Pharmaceuticals
    Genentech
    Kanghong Pharmaceutical